UroGen Pharma Ltd

URGNStocksBiotechnologyUnited StatesNasdaqUSD

Price

$41.18

Today

-1.0%

YTD

+77.9%

About

UroGen Pharma Ltd is a globally recognised pharmaceutical firm that has a strong presence in markets worldwide and is dedicated to delivering groundbreaking therapeutic solutions to improve patient care. Operating in the rapidly evolving pharmaceutical industry, Urogen Pharma Ltd provides specialised solutions in the urology sector. The company concentrates its efforts on creating treatments for uro-oncological diseases that lack effective solutions. UroGen is best known for its chemotherapy product Jelmyto. Monitor the URGN share price by adding it to your eToro watchlist.

Price chart

Closing price history for URGN (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-14.00

P/S (TTM)13.77

P/B (TTM)-15.12

Market cap$1.88B

Cap tierSmall-cap

Industry avg P/E-6.22

Profitability

Gross margin89.85%

EBIT margin-77.02%

Net margin-46.26%

ROEUnknown

ROA-53.15%

Earnings & Revenue

Revenue (TTM)$140.49M

Revenue growth (1Y)+52.9%

EPS (TTM)-$2.76

Free cash flow$-175.90M

Total debt$197.09M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.15

Employees291

Next earnings5 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.